Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Barr Pharmaceuticals Inc. (BRL)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: BRL
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Clolar Decision Aside, Genzyme's Still a Near-Term Sell
Sep 2
•
Mark Mitchell
•
Comment!
A Look at D.E. Shaw's Q408 Holdings: Just for Fun
Apr 22
•
Market Folly
•
2 Comments
Farallon Capital's Q408: Betting on MasterCard
Apr 2
•
Market Folly
•
1 Comment
Eric Mindich's Eton Park Capital Likes Gold
Mar 26
•
Market Folly
•
1 Comment
Moore Capital Investments: Theme Is Economic Recovery
Mar 18
•
Market Folly
•
4 Comments
Caxton Associates 13F Filing for Q408
Mar 17
•
Market Folly
•
2 Comments
Hedge Fund Portfolio Tracking: Paulson & Co., Q4 2008
Feb 17
•
Market Folly
•
1 Comment
A Comparison of M&A Activity During Bull and Bear markets
Jan 30
•
Dr. Kris
•
2 Comments
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008
Jan 15
•
Market Folly
•
Comment!
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
Jan 6
•
Market Folly
•
2 Comments
Generic Drug Price War Ramps Up
Dec 24, 2008
•
SA Editor Judy Weil
•
3 Comments
Five Things Worth Remembering About Healthcare in 2009
Dec 23, 2008
•
Ryan Savitz
•
6 Comments
Hedge Fund Tracking: Eton Park Capital (Eric Mindich), Q3 2008
Dec 23, 2008
•
Market Folly
•
1 Comment
FDA Calendar Update: High Hopes for Amgen's Bone Drug
Dec 21, 2008
•
Mike Havrilla
•
Comment!
Hedge Fund Tracking: Moore Capital Management (Louis Bacon), Q3 2008
Dec 10, 2008
•
Market Folly
•
7 Comments
Strong Dollar's Impact on Pharma vs. Generics
Dec 9, 2008
•
SA Editor Judy Weil
•
Comment!
Hedge Fund Tracking: Paulson & Co. (John Paulson), Q3 2008
Dec 2, 2008
•
Market Folly
•
2 Comments
11 Updated Stocks and the Sad Story They Tell
Nov 25, 2008
•
Eric Fox
•
1 Comment
New Healthcare Cost Containment Index
Nov 20, 2008
•
Mike Havrilla
•
1 Comment
What Are Some of the Best Hedge Fund Managers Doing?
Nov 19, 2008
•
Keith Robison
•
11 Comments
Teva Beats On Profits
Nov 6, 2008
•
Mike Havrilla
•
Comment!
Bullish Outlook for Generic Drugs Post-Election
Nov 3, 2008
•
Mike Havrilla
•
Comment!
Only Abatement of Risk Aversion Will Stop VIX from Further Fall - JP Morgan Strategist
Oct 28, 2008
•
FP Trading Desk
•
1 Comment
Best and Worst Performing S&P 500 Stocks, YTD
Oct 27, 2008
•
Bespoke Investment Group
•
2 Comments
Generic Drug Industry Outperforms Drug and Healthcare ETFs
Oct 17, 2008
•
Mike Havrilla
•
Comment!
Biggest Gainers, Losers Since 9/29
Oct 13, 2008
•
TickerSense
•
2 Comments
Overview and Analysis of the Global Generic Drug Industry
Oct 13, 2008
•
Mike Havrilla
•
Comment!
Summer Surge for Pharma Powers IHE, but Concerns Remain
Sep 11, 2008
•
Don Dion
•
1 Comment
Merger Watch: Barr Pharmaceuticals - Teva Pharmaceutical
Aug 22, 2008
•
The M & A Researcher
•
Comment!
Sector and Stock Performance Since Oil's Peak
Aug 12, 2008
•
Bespoke Investment Group
•
1 Comment
Big Pharma’s Healthy Appetite for Acquisitions
Aug 12, 2008
•
Santosh Sankar
•
1 Comment
Board and Executive Compensation in S&P 500
Aug 6, 2008
•
Richard Shaw
•
6 Comments
Watch for More Coming Biotech Acquisitions
Aug 3, 2008
•
Zacks.com
•
7 Comments
S&P 500's Best and Worst Net Income Change
Aug 3, 2008
•
Richard Shaw
•
4 Comments
Gannon On Investing's July 2008 Blogger Roundtable
Jul 21, 2008
•
Geoff Gannon
•
2 Comments
Teva Buys Barr Pharmaceuticals
Jul 20, 2008
•
Mike Huckman
•
1 Comment
Friday Options Update: MSFT, BAC, MIR, OSTK, GILD, BRL, MAT
Jul 18, 2008
•
Andrew Wilkinson
•
Comment!
Wall Street Breakfast: Must-Know News
Jul 18, 2008
•
SA Editor Eli Hoffmann
•
2 Comments
Is Teva Looking to Buy Barr Pharmaceuticals?
Jul 17, 2008
•
Aaron Katsman
•
1 Comment
Wednesday Options Outlook: XLF, MSFT, BRL, CCL, ARM, BWA, PXP, VIX
Jul 16, 2008
•
Andrew Wilkinson
•
Comment!
Barr and Mylan Invalidate Boehringer Ingelheim's Patent on Mirapex
Jul 6, 2008
•
Aaron F. Barkoff
•
Comment!
1
2
Next Page